glp-1 side effect lawsuit in kentucky Some podiatrists are voicing concerns about a new known as "Ozempic feet." More information on the condition is available here: https://fox59.com/news/national-world/ozempic-feet-the-latest-side-effect -among-glp-1-users-doctors-warn Ozempic® Lawsuit | July 2026

G., Remy, P., Giordana, C., et al

They work on the same biological pathways and should produce similar improvements in metabolic biomarkers

Ranganath LR, Beety JM, Morgan LM, Wright JW, Howland R, Holst JJ

This could include non-invasive neuromodulation techniques (e.g., transcutaneous auricular vagus nerve stimulation), pharmacological enhancement of endogenous GLP-1 release from L-cells, or dietary manipulations designed to optimize postprandial incretin release [39,40]

Regarding approved uses, tesofensine is specifically used to treat obesity, while semaglutide is indicated for both type 2 diabetes and obesity management

As demand for weight-loss treatments increases, some pharmacies have begun offering compounded versions of popular drugs like semaglutide and tirzepatide